Socio Today
Congenital Heart Disease (CHD), known in Indonesia as Penyakit Jantung Bawaan (PJB), remains one of the most significant challenges in pediatric medicine across the archipelago. While the precise etiology of the condition often remains elusive, medical experts are increasingly highlighting preventable risk factors and the urgent need for systemic improvements in early detection. As the second leading cause of neonatal mortality in Indonesia, CHD represents a public health crisis that requires a multi-faceted approach involving maternal education, clinical screening, and infrastructure development.
During a recent clinical webinar, dr. Rizky Adriansyah, MKed, a pediatric specialist and Chairman of the Cardiology Coordination Work Unit of the Indonesian Pediatric Society (IDAI), underscored the complexities surrounding the condition. According to dr. Rizky, while a definitive "cause-and-effect" relationship is difficult to establish for every individual case, several high-risk factors during pregnancy have been identified as major contributors to the development of heart defects in newborns.
The Landscape of Congenital Heart Disease in Indonesia
To understand the gravity of the situation, one must look at the statistical data provided by both national and international health bodies. In Indonesia, data from 2017 indicates that CHD accounts for approximately 17 percent of neonatal deaths, trailing only prematurity as a leading cause of mortality in the first month of life. This figure highlights a critical vulnerability in the country’s pediatric healthcare system.
Global data from the World Health Organization (WHO) suggests that approximately one in every 100 newborns suffers from some form of CHD. More alarmingly, 25 percent of these cases are classified as "critical CHD," which requires immediate medical or surgical intervention within the first few days or weeks of life to ensure survival. In the Indonesian context, this translates to roughly two to four critical cases per 1,000 live births. Despite these numbers, dr. Rizky pointed out a sobering reality: less than 50 percent of CHD cases in Indonesia are currently receiving adequate medical treatment. This treatment gap is attributed to a combination of factors, including geographical barriers to specialized care, a shortage of pediatric cardiologists, limited diagnostic equipment in rural areas, and a general lack of public awareness regarding the symptoms of heart defects in infants.
Identifying and Mitigating Prenatal Risk Factors
The development of the human heart is a complex biological process that occurs very early in pregnancy, often before a woman even realizes she is expecting. Consequently, the window for prevention is narrow and primarily focused on the health and environment of the mother. Dr. Rizky identified three primary risk factors that have gained significant attention in recent medical literature: viral infections, nutritional deficiencies, and pharmacological influences.
1. Viral Infections and the Role of Rubella
One of the most preventable risk factors is the Rubella virus. If a pregnant woman contracts Rubella, particularly during the first trimester, the virus can cross the placenta and interfere with the fetus’s organ development, leading to Congenital Rubella Syndrome (CRS). Heart defects are a hallmark of this syndrome. Dr. Rizky emphasized that the most effective way to combat this risk is through pre-pregnancy vaccination. Ensuring that women of childbearing age are immunized against Rubella can drastically reduce the incidence of infection-related CHD.
2. Nutritional Support and Folic Acid
The importance of folic acid (Vitamin B9) in preventing neural tube defects is well-known, but its role in cardiac development is equally vital. Folic acid aids in DNA synthesis and repair, as well as cell division. A deficiency during the critical weeks of heart formation can lead to structural abnormalities. Medical professionals urge expectant mothers to not only consume folic acid-rich foods—such as leafy greens, legumes, and fortified cereals—but also to take prescribed supplements as early as possible in the reproductive cycle.
3. Pharmacological Risks
The consumption of certain medications during pregnancy can also heighten the risk of CHD. Specifically, dr. Rizky noted that medications used to treat seizures (anticonvulsants) have been linked to an increased risk of heart malformations in the fetus. This presents a complex challenge for women with chronic conditions like epilepsy, necessitating close coordination between neurologists and obstetricians to manage medication dosages or seek safer alternatives during pregnancy.
Beyond these three factors, historical data has long pointed to maternal smoking and alcohol consumption as significant risks. However, dr. Rizky noted an interesting clinical observation: many cases of CHD occur in children whose mothers did not smoke or drink. This suggests that while lifestyle choices are important, they are only part of a much larger, more complex puzzle involving genetics and environmental triggers that science is still working to fully map.
The Challenge of Diagnosis: From Stethoscopes to Oximetry
One of the primary hurdles in reducing CHD-related mortality in Indonesia is the delay in diagnosis. Many children are born appearing healthy, only to deteriorate rapidly once the ductus arteriosus (a temporary blood vessel in the fetal heart) closes shortly after birth.
To address this, the medical community is advocating for simpler, more accessible screening methods. While echocardiography (an ultrasound of the heart) remains the gold standard for diagnosis, it is often unavailable in remote community health centers (Puskesmas). As an alternative, dr. Rizky highlighted the effectiveness of pulse oximetry screening.
Pulse oximetry is a non-invasive, inexpensive, and highly sensitive tool that measures the oxygen saturation in a baby’s blood. By placing sensors on the baby’s right hand and either foot, healthcare providers can detect differences in oxygen levels that indicate a heart defect. This procedure, which takes less than five minutes, is being promoted as a mandatory screening tool for newborns between 24 and 48 hours of age.
Furthermore, the traditional use of the stethoscope remains a vital first line of defense. The presence of a "murmur"—an unusual sound heard between heartbeats—can be an early indicator of structural issues. Dr. Rizky advised that if a murmur is detected during a routine check-up, healthcare providers must immediately prioritize a cardiac evaluation.
Clinical Symptoms and the Role of Primary Care
For infants who are not diagnosed immediately at birth, parents and primary caregivers must be vigilant for clinical signs that appear in the following weeks. One of the most common symptoms of CHD in infants is "failure to thrive," characterized by abnormally slow weight gain. Because the heart has to work harder to pump blood, the infant consumes more energy and may become too exhausted to feed properly.
Other symptoms include:
- Cyanosis: A bluish tint to the skin, lips, or fingernails, indicating low oxygen levels.
- Rapid breathing or shortness of breath during feeding.
- Excessive sweating, particularly during exertion (feeding).
- Frequent respiratory infections.
Dr. Rizky stressed that education is the most powerful tool for early intervention. Through initiatives like the "Sehatkan Jantung Anak Indonesia" YouTube channel, the IDAI aims to empower both parents and frontline healthcare workers, such as midwives, with the knowledge to recognize these red flags. Midwives, who attend a significant portion of births in rural Indonesia, are positioned to be the "first responders" in CHD detection.
Analysis of Implications and Future Outlook
The current state of CHD management in Indonesia reflects a broader struggle within the healthcare system to balance specialized care with geographical accessibility. The fact that less than half of affected children receive treatment suggests a "postcode lottery" where a child’s survival depends largely on their proximity to major urban centers like Jakarta or Surabaya, where specialized cardiac centers are concentrated.
To improve these outcomes, Indonesia must look toward a decentralized model of cardiac care. This involves:
- Human Resource Development: Increasing the number of pediatric cardiologists and specialized cardiac nurses through targeted fellowships and international partnerships.
- Policy Integration: Making newborn pulse oximetry screening a standard, reimbursed protocol under the national health insurance (JKN) scheme.
- Infrastructure: Equipping regional hospitals with basic echocardiography machines and establishing a robust referral network to ensure critical cases are transported to surgical centers without delay.
The economic implications of untreated CHD are also significant. Children with uncorrected heart defects often face a lifetime of chronic illness, placing a long-term burden on the healthcare system and reducing the future workforce’s productivity. Conversely, early surgical intervention often allows these children to lead full, productive lives.
Conclusion
Congenital Heart Disease is a silent crisis among Indonesia’s newborns, but it is a crisis that can be managed through proactive measures. While the exact causes of heart malformations may remain a mystery in many cases, the path to reducing mortality is clear. By focusing on maternal health, expanding the use of simple diagnostic tools like pulse oximetry, and fostering a culture of awareness among parents and midwives, Indonesia can begin to bridge the gap in cardiac care. As dr. Rizky Adriansyah and the IDAI continue to advocate for better screening and education, the goal remains a future where every Indonesian child, regardless of where they are born, has a fighting chance at a healthy heart.
